Tymlos, Evenity Pricing: Should Generic Zoledronic Be Reference Point?
Executive Summary
ICER draft report concluding data are insufficient to distinguish the effectiveness of anabolic treatments for osteoporosis from generic zoledronic acid raises questions about price premiums for the newer treatments.